We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
Cap. Flow
+$1.35B
Cap. Flow %
3.15%
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$21.8M
2
CVX icon
Chevron
CVX
+$20.5M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$19.7M
4
INCY icon
Incyte
INCY
+$17.8M
5
XOM icon
ExxonMobil
XOM
+$16.9M

Top Sells

Rank Stock Value
1
SE
Spectra Energy Corp Wi
SE
+$49.6M
2
STJ
St Jude Medical
STJ
+$41.1M
3
LLTC
Linear Technology Corp
LLTC
+$30.3M
4
HAR
Harman International Industries
HAR
+$13.8M
5
ENH
Endurance Specialty Holdings Ltd
ENH
+$10.3M

Sector Composition

Rank Sector Weight
1 Financials 16.2%
2 Technology 15.06%
3 Healthcare 13.05%
4 Industrials 10.88%
5 Consumer Discretionary 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BELFB
2251
Bel Fuse Inc Class B
BELFB
$3.87B
$497K ﹤0.01%
19,433
+4,644
+31% +$133K
HCKT icon
2252
Hackett Group
HCKT
$270M
$496K ﹤0.01%
25,427
+891
+4% +$16K
GTS
2253
DELISTED
Triple-S Management Corporation
GTS
$495K ﹤0.01%
29,594
-18
-0.1% -$323
COWN
2254
DELISTED
Cowen Inc. Class A Common Stock
COWN
$494K ﹤0.01%
33,047
+1,168
+4% +$17.3K
ASPS icon
2255
Altisource Portfolio Solutions
ASPS
$63.6M
$493K ﹤0.01%
1,675
+44
+3% +$9.75K
CHUBK
2256
DELISTED
CommerceHub, Inc. Series C Common Stock
CHUBK
$493K ﹤0.01%
31,716
+3,168
+11% +$49K
SNC
2257
DELISTED
State National Companies, Inc.
SNC
$493K ﹤0.01%
34,259
+1,052
+3% +$14.6K
SENEA icon
2258
Seneca Foods Class A
SENEA
$1.12B
$489K ﹤0.01%
13,535
+3,177
+31% +$120K
TGTX icon
2259
TG Therapeutics
TGTX
$7.96B
$489K ﹤0.01%
42,017
+1,468
+4% +$10.5K
WMC
2260
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$489K ﹤0.01%
5,001
+159
+3% +$16.1K
FMI
2261
DELISTED
Foundation Medicine, Inc.
FMI
$489K ﹤0.01%
15,158
+668
+5% +$16.7K
LJPC
2262
DELISTED
La Jolla Pharmaceutical Company
LJPC
$489K ﹤0.01%
16,394
+1,554
+10% +$39.7K
BNFT
2263
DELISTED
Benefitfocus, Inc.
BNFT
$488K ﹤0.01%
17,468
+4,013
+30% +$115K
DHT icon
2264
DHT Holdings
DHT
$2.99B
$487K ﹤0.01%
109,000
+4,591
+4% +$21.3K
AD
2265
Array Digital Infrastructure
AD
$3.01B
$485K ﹤0.01%
13,002
+1,637
+14% +$67.4K
BBSI icon
2266
Barrett Business Services
BBSI
$959M
$482K ﹤0.01%
35,320
+1,092
+3% +$16.3K
PDLI
2267
DELISTED
PDL BioPharma, Inc.
PDLI
$482K ﹤0.01%
212,350
+6,568
+3% +$14.5K
TVRD
2268
Tvardi Therapeutics
TVRD
$19.7M
$481K ﹤0.01%
727
+22
+3% +$11.8K
INWK
2269
DELISTED
InnerWorkings, Inc.
INWK
$481K ﹤0.01%
48,265
+1,281
+3% +$12.4K
LOCO icon
2270
El Pollo Loco
LOCO
$501M
$480K ﹤0.01%
40,157
+11,595
+41% +$142K
SHOR
2271
DELISTED
ShoreTel, Inc.
SHOR
$480K ﹤0.01%
78,043
+2,710
+4% +$18.2K
REI icon
2272
Ring Energy
REI
$315M
$479K ﹤0.01%
44,246
+3,616
+9% +$43.9K
AUD
2273
DELISTED
Audacy, Inc.
AUD
$479K ﹤0.01%
33,511
+366
+1% +$5.42K
RVNC
2274
DELISTED
Revance Therapeutics, Inc.
RVNC
$477K ﹤0.01%
22,938
+1,952
+9% +$40.1K
WTBA icon
2275
West Bancorporation
WTBA
$478M
$476K ﹤0.01%
20,759
+745
+4% +$17.2K
89 90
91
92 93

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

RhumbLine Advisers's Q1 2017 Portfolio in Review

As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.

  • RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
  • RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
  • RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
  • RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
  • RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
  • RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.

Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.